Literature DB >> 25727529

Medications for first-episode psychosis: making a good start.

Lisa B Dixon1, T Scott Stroup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25727529     DOI： 10.1176/appi.ajp.2014.14111465

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.

Authors:  Dolores Keating; Stephen McWilliams; Ian Schneider; Caroline Hynes; Gráinne Cousins; Judith Strawbridge; Mary Clarke
Journal:  BMJ Open       Date:  2017-01-06       Impact factor: 2.692

2.  Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

Authors:  Emanuela Martinuzzi; Susana Barbosa; Douglas Daoudlarian; Wafa Bel Haj Ali; Cyprien Gilet; Lionel Fillatre; Olfa Khalfallah; Réjane Troudet; Stéphane Jamain; Guillaume Fond; Iris Sommer; Stefan Leucht; Paola Dazzan; Philip McGuire; Celso Arango; Covadonga M Diaz-Caneja; Wolfgang Fleischhacker; Dan Rujescu; Birte Glenthøj; Inge Winter; René Sylvain Kahn; Robert Yolken; Shon Lewis; Richard Drake; Laetitia Davidovic; Marion Leboyer; Nicolas Glaichenhaus
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 7.989

3.  Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).

Authors:  R Segarra; M Recio-Barbero; M Sáenz-Herrero; O Mentxaka; J Cabezas-Garduño; J I Eguíluz; L F Callado
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

4.  Drug-naïve first-episode schizophrenia spectrum disorders: Pharmacological treatment practices in inpatient units in Hunan Province, China.

Authors:  Mengran Zhu; Maria Ferrara; Wenjian Tan; Xingbo Shang; Sumaiyah Syed; Li Zhang; Qilin Qin; Xinran Hu; Robert Rohrbaugh; Vinod H Srihari; Zhening Liu
Journal:  Early Interv Psychiatry       Date:  2020-09-14       Impact factor: 2.732
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.